Inactive Instrument

Highlights Biofrontera AG OTC Markets

Equities

BFRA

US09075G1058

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M	05-15	MT
Rights Issue: 1 new share @ 1.1 EUR for 1 existing share	05-13	FA
Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023	04-30	CI
Biofrontera AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-28	CI
Earnings Flash (BFRI) BIOFRONTERA Reports Q3 Revenue $8.9M, vs. Street Est of $8.4M	11-09	MT
Biofrontera AG Reports Earnings Results for the Half Year Ended June 30, 2023	31/08/23	CI
Earnings Flash (BFRI) BIOFRONTERA Reports Q2 Revenue $5.8M	11/08/23	MT
Biofrontera Launches Novel Belixos Active Care	05/07/23	CI
Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2023	31/05/23	CI
Biofrontera AG Completes Patient Recruitment of Ameluz Phase I Trial	17/05/23	CI
Biofrontera Says it Obtained US Patent for New Photodynamic Therapy Protocol	15/05/23	MT
Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $8.7M, vs. Street Est of $9.2M	12/05/23	MT
Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23	CI
Biofrontera AG Establishes UK Subsidiary to Strengthen Its Sales Activities in the Country	08/12/22	CI
Biofrontera Ag Continues to Adhere to Forecast for Fiscal Year 2022	23/11/22	CI
Biofrontera AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	23/11/22	CI
Earnings Flash (BFRI) BIOFRONTERA Reports Q3 Revenue $4.3M, vs. Street Est of $4.3M	14/11/22	MT
Biofrontera Says It Has Agreed to Buy Biofrontera AG Options	31/10/22	MT
Rights Issue: 1 new share @ 1 EUR for 8 existing shares	27/10/22	FA
Biofrontera Adopts Shareholder Rights Plan	14/10/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Biofrontera AG OTC Markets

Equities

BFRA

US09075G1058

Highlights

Filters